Dr. Lal Path Labs Ltd. — Updates, 25-06-2025: Press Release

Dr. Lal PathLabs has announced a board meeting to discuss the financial results for the quarter and half-year. The company has expanded its genomics capabilities by integrating Illumina’s NovaSeq X Series into its Genevolve division. This technology significantly boosts sequencing speed and accuracy, enabling over 20,000 whole genomes annually—more than double previous capacity. This move strengthens DLPL’s position in next-generation sequencing, enhancing AI-powered genomic insights and supporting India’s growing genomics research landscape.